IsoniazidRifampinAntitubercular AgentsAntibiotics, AntitubercularMycobacterium tuberculosisPyrazinamideEthambutolTuberculosis, Multidrug-ResistantTuberculosisTuberculosis, PulmonaryMicrobial Sensitivity TestsStreptomycinEthionamideDrug Resistance, BacterialDrug Resistance, MicrobialRifamycinsAminosalicylic AcidsAnti-Bacterial AgentsAminosalicylic AcidRifabutinDrug Therapy, CombinationAza CompoundsMycobacteriumDrug Resistance, Multiple, BacterialDrug Administration ScheduleClofazimineCatalaseColony Count, MicrobialBacterial ProteinsMycobacteriophagesSputumTreatment OutcomeIsonicotinic AcidsDiarylquinolinesOfloxacinQuinolinesDrug InteractionsThioacetazoneTime FactorsLatent TuberculosisMycobacterium smegmatisMycolic AcidsMutationDNA, BacterialDNA-Directed RNA PolymerasesAnti-Infective AgentsArea Under CurveOxidoreductasesHIV InfectionsDrug CombinationsTuberculin TestDirectly Observed TherapyDrug SynergismAntineoplastic Combined Chemotherapy ProtocolsMycobacterium kansasiiLeprostatic AgentsDrug-Induced Liver InjuryArylamine N-AcetyltransferaseHydrazinesDose-Response Relationship, DrugExtensively Drug-Resistant TuberculosisHalf-LifeAdministration, OralAIDS-Related Opportunistic InfectionsSouth AfricaDrug Resistance, MultipleCulture MediaCiprofloxacinChloramphenicolVancomycinStaphylococcal Infections